Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
For in vivo applications where extended half-life is not required, DES(1-3) IGF-1's higher potency allows researchers to achieve equivalent receptor activation at lower administered amounts
[12] [13] [92] In February 2026, a French man, Jean-Marc Laurent, filed what has been described as the first legal complaint related to paternal exposure to valproate, alleging that his child developed neurodevelopmental disorders after he had been treated with the drug prior to conception
Fibroblast-specific TGF--Smad2/3 signaling underlies cardiac fibrosis
Suppliers' Data The Vision Healthcare group engages external service providers and suppliers for various services/products
US$ 27.44
US$ 29.61
US$ 29.71
US$ 25.40
US$ 24.50
US$ 23.32
